Bibliography
- CPS. Compendium of Pharmaceuticals and Specialties. Compendium of Pharmaceuticals and Specialties. Ottawa: Canadian Pharmacist Association; 2007
- The Food and Drug Administration. FDA approves novel medication for smoking cessation. 11 May 2006. Available from: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01370.htm
- The Food and Drug Administration. Early Communication about an ongoing safety review varenicline (marketed as Chantix). 2 November 2007. Available from: http://www.fda.gov/Cder/Drug/early_comm/varenicline.htm
- The US Food and Drug Administration. Varenicline (marketed as Chantix) information. 1 February 2008. Available from: http://www.fda.gov/cder/drug/infopage/varenicline/default.htm
- Moore TJ. Strong safety signal seen for new varenicline risks. The Institute for Safe Medication Practices. 22 May 2008. Available from: http://www.ismp.org/docs/vareniclinestudy.asp
- Federal Aviation Administration. Guide for Aviation Medical Examiners. 23 May 2008. Available from: http://www.faa.gov/about/office_org/headquarters_offices/avs/offices/aam/ame/guide/amcs_login/
- The Federal Motor Carrier Safety Administration. Statement from Administrator John H Hill. The Federal Motor Carrier Safety Administration. 27 May 2008. Available from: http://www.fmcsa.dot.gov/statement-5-23-08.htm
- The Food and Drug Administration. FDA proposes new warnings about suicidal thinking, behavior in young adults who take antidepressant medications. 2 May 2007. Available from: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html
- The Food and Drug Administration. Information for Healthcare Professionals: suicidality and antiepileptic drugs. 31 January 2008. Available from: http://www.fda.gov/cder/drug/advisory/atomoxetine.htm
- The Food and Drug Administration. Public Health Advisory: suicidal thinking in children and adolescents being treated with Strattera (atomoxetine). 29 September 2005. Available from: http://www.fda.gov/cder/drug/advisory/atomoxetine.htm
- The Food and Drug Administration. Early Communication about an ongoing safety review of montelukast (Singulair). 27 March 2008. Available from: http://www.fda.gov/cder/drug/early_comm/montelukast.htm
- The Food and Drug Administration. Memorandum. 22 May 2007. Available from: http://www.fda.gov/ohrms/dockets/ac/07/questions/2007-4306q-fda-questionstocommittee-draft.pdf
- The Food and Drug Administration. FDA briefing document, NDA 21-288. Zimulit (rimonabant) tablets 20 mg. 13 June 2007. Available from: http://www.fda.gov/OHRMS/DOCKETS/AC/07/briefing/2007-4306b1-fda-backgrounder.pdf
- European Medicines Agency Home. European Medicines Agency recommends Acomplia must not be used in patients on antidepressants or with major depression. 19 July 2007. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/acomplia/32982607en.pdf
- Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007;1647:1035-43
- Lilienfeld S, Waldman I, Israel A. A critical examination of the use of the term and concept of “comorbidity” in psychopathology research. Clin Psychol Sci Pract 1994;1:71-83
- Jablensky AKR. Criteria for assessing a classification in psychiatry. In: Mario Mai WGJJLNS, editor, Psychiatric diagnosis and classification. John Wiley & Sons, Ltd.; 2002. p. 1-24
- Nemeroff CB, Kalali A, Keller MB, et al. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007;644:466-72
- Katz LY, Kozyrskyj AL, Prior HJ, et al. Effect of regulatory warnings on antidepressant prescription rates, use of health services and outcomes among children, adolescents and young adults. CMAJ 2008;1788:1005-11
- Gibbons RD, Brown CH, Hur K, et al. Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007;1649:1356-63
- Li TK, Volkow ND, Baler RD, et al. The biological bases of nicotine and alcohol co-addiction. Biol Psychiatry 2007;611:1-3
- Medicines and Healthcare products Regulatory Agency. Drug safety update: volume 1, issue 5, 03 December 2007. Available from: http://www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/CON2033216